FSPKF (Fisher & Paykel Healthcare) Short Ratio


FSPKF Fisher & Paykel Healthcare Corp Ltd FSPKF
91 GF Score
Price $22.52
GF Value $27.30
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FSPKF
91GF Score
Fisher & Paykel Healthcare Corp Ltd FSPKF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of $22.52 is trading 17.5% below its estimated GF Value™ of $27.30. GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.

Key valuation signals for FSPKF:

  • Short Ratio:
  • GF Value™: $27.30 vs. price of $22.52 (17.5% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fisher & Paykel Healthcare Business Description

Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
91GF Score

Get the complete analysis for FSPKF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.52
Price
$27.30
GF Value